Sapphiros and binx health combine as Onvaro around 1,000-device diagnostics network
Sapphiros and binx health combine as Onvaro, pairing a 1,000-device FDA-cleared testing network with a broader diagnostics pipeline.
Medical Devices & Diagnostics
Features & Analysis
KKR is paying $5.7bn for Integer Holdings. Why are medtech suppliers suddenly so attractive to private equity?
KKR’s agreement to acquire Integer Holdings joins the multibillion-dollar privatisation of Hologic and American Industrial Partners’ purchase of Avanos Medical. The transactions differ substantially, but together they show why specialised medtech manufacturers, platforms and established healthcare franchises remain attractive to private capital even when near-term growth is uneven.
Medical Devices & Diagnostics
KKR is paying $5.7bn for a medical-device company patients rarely see. Here is why Integer matters
KKR has agreed to acquire Integer Holdings in a $5.7 billion transaction, taking one of the world’s largest medical-device development and manufacturing partners private. The deal gives KKR exposure to cardiovascular, neuromodulation and cardiac-rhythm technologies, but Integer’s slowing sales and elevated debt show why operational execution will matter after the takeover.
Pharma & Biotech
What KKR’s €1.2bn Medicover India deal means for hospital consolidation
KKR’s €1.2 billion Medicover India deal targets a 24-hospital platform as private capital accelerates India’s healthcare consolidation.